» Articles » PMID: 32010062

New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine

Overview
Specialty Endocrinology
Date 2020 Feb 4
PMID 32010062
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic peripheral neuropathy (DPN) is a common chronic complication of diabetes mellitus. It leads to distressing and expensive clinical sequelae such as foot ulceration, leg amputation, and neuropathic pain (painful-DPN). Unfortunately, DPN is often diagnosed late when irreversible nerve injury has occurred and its first presentation may be with a diabetic foot ulcer. Several novel diagnostic techniques are available which may supplement clinical assessment and aid the early detection of DPN. Moreover, treatments for DPN and painful-DPN are limited. Only tight glucose control in type 1 diabetes has robust evidence in reducing the risk of developing DPN. However, neither glucose control nor pathogenetic treatments are effective in painful-DPN and symptomatic treatments are often inadequate. It has recently been hypothesized that using various patient characteristics it may be possible to stratify individuals and assign them targeted therapies to produce better pain relief. We review the diagnostic techniques which may aid the early detection of DPN in the clinical and research environment, and recent advances in precision medicine techniques for the treatment of painful-DPN.

Citing Articles

Nerve Conduction Study, Sympathetic Skin Response Test, and Demographic Correlates in Type 2 Diabetes Mellitus Patients.

Lee Y, Kim S, Kim C Ann Rehabil Med. 2025; 49(1):40-48.

PMID: 39910961 PMC: 11895056. DOI: 10.5535/arm.240042.


Clinical Trial: Effect of Autologous Dendritic Cell Administration on Improving Neuropathy Symptoms and Inflammatory Biomarkers in Diabetic Neuropathy.

Setiawan E, Ginting C, Jonny J, Hernowo B, Putranto T Curr Issues Mol Biol. 2024; 46(12):14366-14380.

PMID: 39727989 PMC: 11674235. DOI: 10.3390/cimb46120861.


Consumer Understanding of Prescription Drug Indications in Direct-to-Consumer Television Advertisements.

Sullivan H, Aikin K, Johnson M, Ferriola-Bruckenstein K Ther Innov Regul Sci. 2024; 59(2):278-287.

PMID: 39702850 PMC: 11879756. DOI: 10.1007/s43441-024-00732-4.


Exosome-based drug delivery systems for the treatment of diabetes and its complications: current opinion.

Chen Q, Chen J, Liu Y, Qi S, Huang L Extracell Vesicles Circ Nucl Acids. 2024; 4(3):502-517.

PMID: 39698026 PMC: 11648477. DOI: 10.20517/evcna.2023.32.


Development of a near infrared region based non-invasive therapy device for diabetic peripheral neuropathy.

Rajeswari S, Ponnusamy V, Zdravkovic N, Kisic E, Padmajothi V, Vijayalakshmi S Sci Rep. 2024; 14(1):27993.

PMID: 39543326 PMC: 11564650. DOI: 10.1038/s41598-024-78144-5.


References
1.
Chatzikosma G, Pafili K, Demetriou M, Vadikolias K, Maltezos E, Papanas N . Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus. Arch Med Sci. 2016; 12(2):390-3. PMC: 4848369. DOI: 10.5114/aoms.2016.59265. View

2.
Cameron N, EATON S, Cotter M, Tesfaye S . Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001; 44(11):1973-88. DOI: 10.1007/s001250100001. View

3.
Demant D, Lund K, Vollert J, Maier C, Segerdahl M, Finnerup N . The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study. Pain. 2014; 155(11):2263-73. DOI: 10.1016/j.pain.2014.08.014. View

4.
Dyck P, Kratz K, Karnes J, Litchy W, Klein R, Pach J . The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993; 43(4):817-24. DOI: 10.1212/wnl.43.4.817. View

5.
Pittenger G, Ray M, Burcus N, McNulty P, Basta B, Vinik A . Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care. 2004; 27(8):1974-9. DOI: 10.2337/diacare.27.8.1974. View